Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1662 of 6351
-
New gel promises better nerve repair after severe arm injuries
Disease control Recruiting nowNTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.
Phase 3 • Sponsor: Neuraptive Therapeutics Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new eye test match the gold standard for glaucoma?
Diagnosis Completedthis study seeks to compare the Humphrey Visual Field Analyzer and iCare COMPASS for both clinical accuracy and operational advantages.
Sponsor: Indiana University • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New Orexin-Like pill could fight extreme daytime sleepiness
Symptom relief Recruiting nowIdiopathic Hypersomnia (IH) is a condition where people feel extremely sleepy during the day, especially in the morning, even if they sleep a lot at night. They may have trouble waking up in the morning, no matter how much they sleep (sometimes more than 11 hours per day), and th…
Phase 2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer? early trial launches
Disease control Recruiting nowThis is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)
Phase 1/2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Heart failure patients get a High-Tech watchdog: implanted sensor aims to cut hospital visits
Disease control Recruiting nowThis retrospective, non-randomized cohort study will evaluate how well the Cordella PA Sensor System works compared to standard medication treatment in people with chronic heart failure. The study will track patients for two years to see if those using the Cordella system have fe…
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New heart procedure offers hope for stubborn chest pain
Disease control OngoingVariant angina, also known as vasospastic angina, is a form of chest pain caused by temporary spasms of the coronary arteries, which reduce blood flow to the heart. These spasms often occur at rest and may lead to serious complications, including life-threatening heart rhythm pro…
Sponsor: Zhibing Lu • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a cancer drug ease long COVID? new trial aims to find out
Symptom relief OngoingThe study aims to prove that plitidepsin could be an efficacious, safe, and well-tolerated therapy for PCC. To this end, we will perform a randomized, double-blind study comparing the clinical and laboratory benefits of plitidepsin vs. placebo in 90 subjects with moderate to seve…
Phase 2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Off-the-Shelf immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, multi-center phase 1 clinical study designed to evaluate the safety and preliminary efficacy of NK042 cell injection in patients with advanced solid tumors.
Phase 1 • Sponsor: Shanghai NK Cell Technology Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a cancer drug stop a blood disorder before it turns deadly?
Disease control Recruiting nowThis research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unknown Significance (CCUS). This study will give eligible CCUS participants the option of either being observed or taking an …
Early phase 1 • Sponsor: Lachelle D. Weeks, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
AI-Powered ultrasound could spot hidden heart valve disease in minutes
Diagnosis CompletedThis is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI ba…
Sponsor: Caption Health, Inc. • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New program aims to boost sleep apnea treatment in native elders to fight dementia risk
Disease control Recruiting nowThis research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The pr…
Sponsor: Washington State University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy targets tough leukemia in older patients
Disease control Recruiting nowTo search for a Maximum Tolerated Dose (MTD) for the combination of daratumumab and induction chemotherapy with Idarubicin and cytarabine or CPX-351 in patients with Acute Myeloblastic Leukemia (AML) of poor prognosis
Phase 1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New heart failure pill shows promise in early trial
Disease control Recruiting nowThis is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.
Phase 2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Robot glove aims to boost stroke recovery in landmark trial
Disease control Recruiting nowThis multicenter international randomized controlled trial (RCT) evaluates the effectiveness of the Gloreha Sinfonia® robotic exoskeleton for upper limb rehabilitation in individuals with subacute post-stroke paresis. The study aims to determine whether robotic-assisted therapy i…
Sponsor: IRCCS San Raffaele Roma • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on lupus and scleroderma in first human test
Disease control OngoingCALiPSO-1 is a Phase 1, multi-centre, dose-confirmation study to evaluate the safety and efficacy of CNTY-101 in participants with refractory B cell-mediated autoimmune diseases including those with moderate to severe systemic lupus erythematosus (SLE) with or without lupus nephr…
Phase 1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Second chance: can a new valve fix a failing TAVR without open surgery?
Disease control Recruiting nowThe purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Preventive radiation may stop bone metastases from causing fractures
Disease control Recruiting nowThe goal of this clinical trial is to learn whether radiotherapy (i.e. treatment with ionizing radiation to destroy cancer cells) can prevent symptoms in patients with metastatic cancer, having high-risk bone metastases that currently result in no or only mild symptoms. High-risk…
Sponsor: Cancer Research Antwerp • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could fewer calories save more lives? new trial for malnourished kids
Disease control OngoingThe goal of this clinical trial is to learn if giving lower calorie feeds during the first stage of treatment helps improve survival in severely malnourished children who are ill. The main question it aims to answer is: Is it safe to feed ill severely malnourished children lower…
Phase 1 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cooking classes and tailored groceries could help teens manage weight
Disease control Recruiting nowThe proposed project aims to implement and evaluate a novel, family-based lifestyle medicine intervention integrating group Shared Medical Appointments (SMAs) for parents and adolescents with a twelve-month medically tailored groceries (MTG) and six-month culinary medicine Food i…
Sponsor: Tufts University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for rare blood disorder: dupilumab combo trial launches
Disease control Recruiting nowBackground: Hypereosinophilic syndrome (HES) is a blood disorder that causes high levels of white blood cells called eosinophils. HES can damage the lungs and airways, intestines, skin, and other organs. The current primary treatment for HES can cause serious side effects. Secon…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC